Federated Hermes
EVLO

Federated Hermes’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Federated Hermes’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,522
Closed -$754K – 2370
2021
Q1 		$754K Buy
3,522
+3,521
+352,100% +$973K ﹤0.01% 1471
2020
Q4 		$1K Buy
+1
New +$124 ﹤0.01% 2207

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Federated Hermes's EVLO Position: Q2 2021 in Review

Federated Hermes sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2021, closing a stake of 3,522 shares — an estimated $754K sold.

Federated Hermes first reported a position in EVLO in Q4 2020 and held it in 2 quarters. The position peaked at $754K in Q1 2021. 66 funds tracked by Wall St. Rank hold EVLO as of Q2 2021.

  • Federated Hermes reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Federated Hermes sold 3,522 Evelo Biosciences, Inc. Common Stock shares in Q2 2021, an estimated $754K.
  • Federated Hermes first reported a position in Evelo Biosciences, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Federated Hermes's Evelo Biosciences, Inc. Common Stock position peaked at $754K in Q1 2021.
  • 66 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2021.

Based on Federated Hermes's 13F filing for Q2 2021, filed 16 Aug 2021.